SELFPHARMA

Active Private limited companyfounded 2008active for 18 yearsBaraplein 2, 1070 AnderlechtKBO/BCE: BE 0806.621.811

SELFPHARMA

Financial year 2025

Follow Report Compare

Annual accounts 2025

abbreviated format, filed on 11-10-2026, 72 days late

€350,855

€74,664

€50,557

€787,905

52.6%

4.53

The turnover shown is an estimate from the gross margin.

Turnover ≈ €1.3m. Estimated: probably between €950,000 and €2.0m.

Balance sheet

balance sheet total €1.4m on 31-12-2025

What the company ownsHow it is paid for

Position in the sector

Compare with sector

52.6%

Higher than 67% of 13,234 companies in 2025.

4.53

Higher than 87% of 13,093 companies in 2025.

3.7%

Higher than 46% of 13,156 companies in 2025.

SELFPHARMA Middle half of the sector 80% of the sector Abbreviated accounts in retail trade (NACE 47)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter · Staff: middle half

Staff

€48,446

Staff costs divided by the average number of full-time equivalents.

people who joined people who left

Filed annual accounts

as filed with the National Bank, click a year to choose it

Line	2025	2023	2022	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	200915 months
Balance sheet: assets
`20/58`	1.4m	1.3m	1.2m	922,628	711,709	751,128	727,449	733,070	734,666	638,787	437,227	548,681	516,201	524,102	619,732
`21/28`	345,755	301,349	233,615	234,974	201,543	229,718	287,254	335,173	339,434	368,465	145,252	191,806	239,316	291,072	341,145
`21`	-	-	-	-	-	-	24,800	49,600	74,400	99,200	124,000	148,800	173,600	198,400	223,200
`22/27`	345,530	301,124	233,390	234,749	201,318	229,493	262,229	285,348	264,809	269,040	21,027	42,781	65,491	92,672	117,945
`22`	117,000	130,000	143,000	169,000	182,000	195,000	208,000	221,000	234,000	247,000	-	-	-	-	-
`23`	23,969	162,386	75,384	65,749	653	1,001	660	1,190	2,431	3,022	2,133	4,204	2,720	4,080	5,440
`24`	50	8,738	15,006	-	18,664	33,491	53,569	63,158	28,378	19,018	18,894	38,577	62,771	88,592	112,505
`26`	204,511	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`28`	225	225	225	225	225	225	225	225	225	225	225	225	225	-	-
`29/58`	1.0m	956,495	965,369	687,654	510,166	521,411	440,195	397,896	395,231	270,322	291,975	356,875	276,885	233,029	278,587
`29`	472,000	472,000	560,000	-	-	-	-	-	-	-	-	-	-	-	-
`291`	472,000	472,000	560,000	-	-	-	-	-	-	-	-	-	-	-	-
`3`	127,559	162,096	169,273	60,605	30,859	40,422	36,065	52,085	58,446	60,151	72,244	82,464	117,033	102,296	108,642
`30/36`	127,559	162,096	169,273	60,605	30,859	40,422	36,065	52,085	58,446	60,151	72,244	82,464	117,033	102,296	108,642
`40/41`	238,663	198,341	103,678	441,048	410,029	341,160	277,306	257,019	265,335	121,781	150,044	155,979	61,700	63,490	62,077
`40`	132,649	166,951	86,940	85,711	76,024	75,782	68,934	91,383	119,961	44,582	74,260	60,849	57,516	50,385	51,970
`41`	106,015	31,391	16,738	355,337	334,005	265,377	208,373	165,636	145,374	77,199	75,784	95,131	4,183	13,105	10,107
`54/58`	167,028	117,875	128,486	183,469	69,278	139,829	126,824	88,793	71,451	88,390	69,687	118,431	98,152	67,243	105,567
`490/1`	6,002	6,183	3,931	2,533	-	-	-	-	-	-	-	-	-	-	2,300
Balance sheet: equity and liabilities
`10/49`	1.4m	1.3m	1.2m	922,628	711,709	751,128	727,449	733,070	734,666	638,787	437,227	548,681	516,201	524,102	619,732
`10/15`	713,435	632,807	596,253	365,010	319,108	255,988	224,484	182,688	157,928	116,961	107,153	182,644	131,140	75,771	51,500
`10/11`	20,460	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`10`	-	18,600	18,600	-	-	-	-	-	-	-	-	-	-	-	-
`100`	-	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`13`	166,500	123,360	123,360	346,410	300,508	237,388	205,884	164,088	139,328	98,361	88,553	164,044	112,540	57,171	32,900
`130/1`	166,500	123,360	123,360	1,860	-	-	-	-	-	-	-	-	-	-	-
`130`	-	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860
`1311`	166,500	121,500	121,500	-	-	-	-	-	-	-	-	-	-	-	-
`133`	-	-	-	344,550	298,648	235,528	204,024	162,228	137,468	96,501	86,693	162,184	110,680	55,311	31,040
`14`	526,475	490,847	454,293	-	-	-	-	-	-	-	-	-	-	-	-
`17/49`	643,572	625,036	602,731	557,619	392,601	495,140	502,965	550,382	576,738	521,826	330,074	366,037	385,061	448,330	568,232
`17`	420,225	410,035	294,818	282,900	215,510	227,430	276,672	322,226	314,934	350,531	166,441	199,092	235,494	270,912	303,022
`170/4`	420,225	410,035	294,818	282,900	215,510	227,430	276,672	322,226	314,934	350,531	166,441	199,092	235,494	270,912	303,022
`42/48`	223,347	215,001	307,913	274,719	177,091	267,711	226,293	228,156	261,804	171,295	163,632	166,944	149,567	177,418	265,209
`42`	20,445	3,851	3,780	722	17,788	55,045	45,589	44,986	34,747	30,611	32,264	36,402	35,418	34,413	32,923
`43`	-	-	-	50,000	-	50,000	-	-	-	-	-	-	-	-	-
`430/8`	-	-	-	50,000	-	50,000	-	-	-	-	-	-	-	-	-
`44`	133,266	178,993	194,245	144,248	76,228	109,960	135,429	125,037	168,665	107,641	97,300	81,311	53,884	52,542	62,997
`440/4`	133,266	178,993	194,245	144,248	76,228	109,960	135,429	125,037	168,665	107,641	97,300	81,311	53,884	52,542	62,997
`45`	69,636	32,156	109,888	79,749	83,074	52,706	45,275	58,132	58,392	33,043	34,069	49,232	38,734	10,872	13,922
`450/3`	21,436	5,753	84,124	42,102	31,151	7,419	18,898	36,432	37,272	25,896	29,463	38,937	34,027	10,726	13,922
`454/9`	48,200	26,404	25,764	37,647	51,924	45,287	26,377	21,701	21,120	7,147	4,606	10,295	4,707	147	-
`47/48`	-	-	-	-	-	-	-	-	-	-	-	-	21,531	79,591	155,367
Income statement
`76A`	-	-	16,268	38,424	-	-	7,809	8,145	-	3,103	16,923	-	-	-	21,802
`9900`	350,855	357,114	328,903	237,667	313,733	303,653	289,640	263,855	280,889	259,477	237,048	254,120	267,499	195,613	186,937
`62`	222,852	233,232	183,911	145,906	175,349	167,878	144,710	150,774	145,990	134,144	100,282	111,582	116,722	91,639	97,757
`630`	48,880	29,374	27,677	19,331	33,773	59,721	61,099	60,073	52,555	54,450	88,708	54,264	52,913	52,690	52,166
`640/8`	4,459	8,712	9,567	8,414	7,086	8,902	6,559	8,179	6,161	5,339	6,125	8,733	8,971	5,427	10,005
`66A`	-	-	-	22,637	-	9,000	-	-	-	-	17,017	-	-	-	-
`9901`	74,664	85,796	107,747	64,016	97,524	58,152	77,273	44,829	76,184	65,544	41,933	79,541	88,893	45,858	27,008
`75/76B`	10,000	1,754	20,400	38,424	-	22	7,809	8,158	155	239	501	897	327	13	49
`75`	10,000	1,754	20,400	-	-	22	-	14	155	239	501	897	327	13	49
`76B`	-	-	-	38,424	-	-	7,809	8,145	-	-	-	-	-	-	-
`65/66B`	18,509	23,668	20,989	37,887	15,687	16,784	24,512	15,784	13,738	12,090	6,541	7,573	10,320	9,042	2,173
`65`	18,509	23,668	20,989	15,250	15,687	16,784	24,512	15,784	13,738	12,090	6,541	7,573	10,320	9,042	2,173
`66B`	-	-	-	22,637	-	-	-	-	-	-	-	-	-	-	-
`9903`	66,155	63,883	107,159	64,554	81,837	41,389	60,570	37,204	62,601	56,795	35,799	72,864	78,900	36,828	46,686
`67/77`	15,598	27,329	31,560	18,652	18,717	9,885	18,774	12,444	21,634	16,987	11,290	21,360	23,532	10,156	13,786
`9904`	50,557	36,554	75,599	45,901	63,120	31,504	41,796	24,760	40,967	39,808	24,509	51,505	55,368	26,671	32,900
`9905`	50,557	36,554	75,599	45,901	63,120	31,504	41,796	24,760	40,967	39,808	24,509	51,505	55,368	26,671	32,900
Appropriation of the result
`9906`	576,475	490,847	529,892	45,901	63,120	31,504	41,796	24,760	40,967	39,808	24,509	51,505	55,368	26,671	32,900
`14P`	525,918	454,293	454,293	-	-	-	-	-	-	-	-	-	-	-	-
`791/2`	-	-	-	-	-	-	-	-	-	-	75,491	-	-	-	-
`691/2`	50,000	-	75,599	45,901	63,120	31,504	41,796	24,760	40,967	9,808	-	51,505	55,368	24,271	32,900
`6920`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,860
`6921`	50,000	-	75,599	45,901	63,120	31,504	41,796	24,760	40,967	9,808	-	51,505	55,368	24,271	31,040
`694/7`	-	-	-	-	-	-	-	-	-	30,000	100,000	-	-	2,400	-
`694`	-	-	-	-	-	-	-	-	-	30,000	100,000	-	-	2,400	-
Social balance sheet
`9087`	4.6	5.1	5	5.8	6.4	4.7	4.4	4.5	4.3	4.7	2.6	2.7	3	2.8	3
Hours worked`1013`	7,154	7,913	6,963	7,748	9,717	8,433	7,092	6,801	6,504	6,713	4,158	4,309	4,337	4,909	4,268
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

The notes to these accounts have 14 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 11-10-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	11-10-2026	2026-00553393	PDF
31-12-2023	full format	30-08-2024	2024-00410851	PDF
31-12-2022	micro format	24-04-2024	2024-00067798	PDF
31-12-2020	full format	29-10-2021	2021-75800239	PDF
31-12-2019	full format	30-09-2020	2020-57500558	PDF
31-12-2018	full format	28-09-2019	2019-67300270	PDF
31-12-2017	full format	27-09-2018	2018-65900376	PDF
31-12-2016	full format	29-09-2017	2017-64800310	PDF
31-12-2015	full format	27-10-2016	2016-66700426	PDF
31-12-2014	full format	30-09-2015	2015-63300554	PDF
31-12-2013	full format	19-09-2014	2014-59700175	PDF
31-12-2012	full format	27-09-2013	2013-61000347	PDF
31-12-2011	full format	28-08-2012	2012-47300263	PDF
31-12-2010	full format	08-07-2011	2011-28400573	PDF
31-12-2009	full format	20-08-2010	2010-44200519	PDF

Key figures and ratios

per financial year, computed from the annual accounts

2025	2023	2022	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	200915 months
123,544	115,170	135,425	83,347	131,297	117,873	138,372	104,902	128,739	119,994	130,641	133,805	141,806	98,547	79,175
99,437	65,928	103,276	65,233	96,893	91,225	102,895	84,833	93,522	94,258	113,217	105,769	108,281	79,361	85,066
36,998	97,107	-	67,900	5,598	2,185	13,179	55,812	23,524	277,664	42,154	6,754	1,157	2,617	393,311
-	-10,610	-	114,191	-70,551	13,005	38,032	17,342	-16,939	18,702	-48,744	20,280	30,909	-38,325	-
787,905	741,494	657,456	412,935	333,075	253,700	213,903	169,741	133,427	99,027	128,343	189,931	127,318	55,611	13,377
52.6%	50.3%	49.7%	39.6%	44.8%	34.1%	30.9%	24.9%	21.5%	18.3%	24.5%	33.3%	25.4%	14.5%	8.3%
4.53	4.45	3.14	2.50	2.88	1.95	1.95	1.74	1.51	1.58	1.78	2.14	1.85	1.31	1.05
3.96	3.69	2.59	2.28	2.71	1.80	1.79	1.52	1.29	1.23	1.34	1.64	1.07	0.74	0.64
0.90	0.99	1.01	1.53	1.23	1.93	2.24	3.01	3.65	4.46	3.08	2.00	2.94	5.92	11.03
7.1%	5.8%	12.7%	12.6%	19.8%	12.3%	18.6%	13.6%	25.9%	34.0%	22.9%	28.2%	42.2%	35.2%	63.9%
3.7%	2.9%	6.3%	5.0%	8.9%	4.2%	5.7%	3.4%	5.6%	6.2%	5.6%	9.4%	10.7%	5.1%	5.3%
6.67	4.87	6.45	-	-	-	-	-	-	-	-	-	-	-	-

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item	31-12-2025	31-12-2023	31-12-2022
Employees at the balance-sheet date	5	6	6
full-time	3	4	3
part-time	2	2	3
in full-time equivalents	4.6	5.6	5.1
	4.6	5.1	5
On a permanent contract	5	5	5
Joined	-	2	2
Left	-	2	0

Source: social balance sheet in the 2022 to 2025 annual accounts

Investments

fixed assets acquired

Item	2025	2023	2022
Tangible fixed assets	€36,998	€97,107	-
	€48,880	€29,374	€27,677

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on SELFPHARMA

The operating result for 2025 is €74,664, against €85,796 in 2023. Comparable figures for the intervening years are unavailable.

Debt's share of the balance-sheet total is 47.4%.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

Annual accounts 2025

Balance sheet

Change in equity

Change in cash

Position in the sector

Solvency52.6%

Current ratio4.53

Return on assets3.7%

Staff

Staff cost per FTE€48,446

Joined and left

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on SELFPHARMA

Next steps

52.6%

4.53

3.7%

€48,446